This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.
In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.
In your application messsage, please share your background and what you can contribute to the group.
Company Overview and News
U.S. retail sales witnessed a solid rise in June as households boosted spending on various products, while demand for automobiles jumped the highest in three months. Continued upswing in retail spending for the fifth straight month has raised expectations of robust economic growth in the second half of 2018. Going forward, an impressive workforce market scenario, higher wage rates and lower taxes will likely stuff more money into wallets and keep demand strong.
VC MGA OSK MG VEEV 7269 MTOR SGH
Vehicle launches and thriving economy are driving new vehicle sales. This upside has encouraged automotive manufacturers to ramp-up vehicle production, which in turn, has led to sales growth for the original equipment manufacturers (OEMs), which supply required auto parts and components for vehicle production.
UFAB MGA AXL MTOR
Chicago, IL – July 9, 2018 – Today, Zacks Equity Research discusses the Industry: Original Equipment, including Autoliv, Inc. (ALV - Free Report) , Meritor Inc. (MTOR - Free Report) and American Axle Manufacturing Holdings, Inc. (AXL - Free Report) .
WFC WFCNP WFC.WS WFC.PRL WDC WFC.PRJ WFC.PRT WFC.PRR WFC.PRQ MTH WFC.PRP WFC.PRO WFC.PRN ALV MTOR CVRR WFC.PRY WFC.PRX WFC.PRW WFC.PRV DIS
Meritor, Inc. (MTOR - Free Report) was a big mover last session, as the company saw its shares rise more than 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $20.35 to $21.77 in the past one-month time frame.
ALV MTOR CVRR FSLR
Improving global economic conditions and an array of vehicle launches have encouraged customers to buy new vehicles. This, in turn, has increased the demand for components, which has led to amplified sales for the Original Equipment Manufacturing industry over the past few years.
Thanks to high consumer confidence and low unemployment, the auto industry has proved resilient so far in 2018, dodging the negative impacts of higher gas prices, rising interest rates and tariff threats. Auto sales rose 1.8% from the year-ago level in the first six months and 5% in June according to Edmunds.com (read: Trade, Fed & Oil Wrote Top ETF Stories of 1H). Of the six major American and Japanese automakers, Fiat Chrysler (FCAU - Free Report) and General Motors (GM - Free Report) have led the way this year with their auto sales up 4.
VC AXL GM.WS.A GM.WS.B GM.WS.C MTOR GM GM.WSB CARZ
Wall Street has lately been on a choppy ride, with the Dow Jones dropping for the sixth consecutive session on tariff tantrum and erasing of all the gains made this year. The most recent sell-off came after Trump threatened to impose tariffs of up to $400 billion on Chinese goods on top of the $50 billion goods announced on Jun 15. This is the latest escalation in a tit-for-tat tariff dispute between the two world’s largest economies that could spiral into a trade war.
MU MTOR CC CEO HCLP
Document SECURITIES AND EXCHANGE COMMISSION
Bargain hunting or looking for stocks with a low price-to-earnings (P/E) ratio is among the widely-used investing strategies. Investors believe that the lower the P/E, the higher will be the value of the stock. The logic is simple — a stock’s current market price does not justify its higher earnings and therefore leaves room for upside.
MATW AIMC XOM PATK FOE MTOR
A month has gone by since the last earnings report for Meritor, Inc. (MTOR - Free Report) . Shares have added about 5.3% in that time frame.
LHC Group, Inc. (LHCG - Free Report) : This health care provider has seen the Zacks Consensus Estimate for its current year earnings increasing 17.4% over the last 60 days.
WFC WFCNP WFC.WS WFC.PRL LHCG WFC.PRJ SMCI WFC.PRT WFC.PRR WFC.PRQ WFC.PRP WFC.PRO WFC.PRN MTOR WFC.PRY WFC.PRX WFC.PRW WFC.PRV CLUB
Chicago, IL – May 30, 2018 - Stocks in this week’s article Pilgrim's Pride Corp. (PPC - Free Report) , NutriSystem Inc (NTRI - Free Report) , Wabco Holdings Inc. (WBC - Free Report) , Matthews International Corp. (MATW - Free Report) and Meritor Inc. (MTOR - Free Report) .
HD NTRI WBC TXN MATW GM.WS.A GM.WS.B GM.WS.C MTOR GM GM.WSB PPC
Meritor, Inc. (MTOR - Free Report) has been performing well lately. The company has a market capitalization of roughly $1.9 billion. The stock has moved up 6.8% in the past month, outperforming 5.2% growth recorded by the industry. The company has a VGM Score of A. This stock, with strong fundamentals and solid long-term growth opportunities, can be considered a solid bet now. Strong Q2 Performance & Upbeat Outlook Meritor’s second-quarter fiscal 2018 results improved on a year-over-year basis.
LKSD MARK TXN OSK MTOR ALSN LKSD.WI
Investors love stocks with a low price-to-earnings (P/E) ratio. The perception is that the lower the P/E, the higher will be the value of the stock. The simple logic that a stock’s current market price does not justify (is not equivalent to) its higher earnings and therefore has room to run is behind investors’ inclination toward low P/E stocks.
NTRI WBC MATW MTOR PPC MRC
Glenview Capital Management’s 13F portfolio value decreased from $18.50B to $17.10B this quarter. The number of positions decreased from 58 to 52.
LOW ATHTF FLEX LBTY KMI.WS WBA ENL CVS HPE SHPG NWL LBTYK KMI.PRA KMI LILAB HCA WMB DOW MTOR CAH KMR DXC AET CVB CMCSK IQV ABBV EBAY EBAYL PNR MIK TMUSP WP TMUS BKD UHS CBS.WD CAR VER CNDT GOOGL LILAK RLGY ABBV CPV MHK ESRX TLRD ENDP LH FB DNB PAH TMO CCV MCK KDNUU CCZ GOOG DLPH AGN CCE AAPL MON CI ARMK CBS CSC CBS.A LYB CMCSA FTI.WI FMC LBTYB LBTYA FDX ANTM HUM DWDP KND ABC V CCV.CL FDC LALWF THC KMRFZ HTZ APTV ANTX LILA
8h - Asif
History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...
9h - Asif
Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...
2018-07-16 - Asif
General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...
Silicon Investor Message Boards
This table lists all message boards related to MTOR / Meritor, Inc. on message board site Silicon Investor.
as of ET